Total planned funding: $197,803,014
Allocations
Countries/Regions
| Eswatini | $197,803,014 |
Organizational Types
| Private Contractor | $48,548,762 |
| University | $38,671,572 |
| NGO | $38,032,583 |
| Unknown | $31,721,387 |
| Own Agency | $24,258,389 |
| Host Country Government Agency | $7,033,459 |
| FBO | $6,188,454 |
| Other USG Agency | $1,878,408 |
| Multi-lateral Agency | $880,000 |
| Implementing Agency | $590,000 |
Program Areas
| Care | $60,921,193 |
| Prevention | $38,729,969 |
| Treatment | $38,070,958 |
| Governance and Systems | $24,694,866 |
| Testing | $19,324,001 |
| Management and Operations | $16,062,027 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $31,277,310 |
| HBHC: Care: Adult Care and Support | $29,732,592 |
| HVCT: Testing: HIV Testing and Counseling | $19,324,001 |
| HKID: Care: Orphans and Vulnerable Children | $16,715,195 |
| HVMS: Management and Operations | $16,062,027 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $14,113,889 |
| HVSI: Strategic Information | $10,779,437 |
| HVTB: Care: TB/HIV | $10,357,006 |
| OHSS: Health Systems Strengthening | $10,172,508 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $8,834,345 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $8,211,891 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $7,197,844 |
| HTXD: Treatment: ARV Drugs | $4,432,964 |
| PDCS: Care: Pediatric Care and Support | $4,116,400 |
| HLAB: Laboratory Infrastructure | $3,742,921 |
| PDTX: Treatment: Pediatric Treatment | $2,360,684 |
| HMBL: Biomedical Prevention: Blood Safety | $372,000 |
| HMIN: Biomedical Prevention: Injection Safety | $0 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Columbia University:
$32,029,037
Countries/Regions
Not Available:
$27,172,401
Countries/Regions
Pact, Inc.:
$23,083,473
Countries/Regions
USG Aggregated Agencies:
$13,954,710
Countries/Regions